Alternative strategies for functionalizing CAR-T cells: engineering without genetic modification

Published: 19 May 2021
Editorial
Carolyn Porter
Carolyn Porter
CEO, Cytoseek

Carolyn Porter, CEO, Cytoseek

 “As fifth generation CAR-T cells reach their limits for modifications facilitated by genetic engineering, new enhancement strategies independent of genetic modification are in development.”

Read now